Schonfeld Strategic Advisors LLC Adma Biologics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $14.6 Billion
  • Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 14,896 shares of ADMA stock, worth $233,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,896
Holding current value
$233,420
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.98 - $11.18 $89,078 - $166,537
14,896 New
14,896 $166,000
Q2 2023

Aug 14, 2023
SELL
$3.12 - $4.22 $241,840 - $327,104
-77,513 Reduced 72.89%
28,835 $106,000
Q1 2023

May 15, 2023
SELL
$3.01 - $3.87 $769,852 - $989,810
-255,765 Reduced 70.63%
106,348 $352,000
Q4 2022

Feb 14, 2023
SELL
$2.47 - $3.88 $1.18 Million - $1.85 Million
-476,353 Reduced 56.81%
362,113 $1.4 Million
Q3 2022

Nov 14, 2022
SELL
$2.03 - $2.86 $446,955 - $629,700
-220,175 Reduced 20.8%
838,466 $2.04 Million
Q2 2022

Aug 15, 2022
SELL
$1.43 - $2.2 $258,851 - $398,233
-181,015 Reduced 14.6%
1,058,641 $2.1 Million
Q1 2022

May 16, 2022
BUY
$1.28 - $1.83 $715,484 - $1.02 Million
558,972 Added 82.12%
1,239,656 $2.27 Million
Q4 2021

Feb 14, 2022
BUY
$1.09 - $1.66 $659,105 - $1 Million
604,684 Added 795.64%
680,684 $960,000
Q3 2021

Nov 16, 2021
SELL
$1.13 - $1.65 $413,436 - $603,690
-365,873 Reduced 82.8%
76,000 $86,000
Q2 2021

Aug 16, 2021
SELL
$1.51 - $2.07 $378,125 - $518,356
-250,414 Reduced 36.17%
441,873 $707,000
Q1 2021

May 17, 2021
BUY
$1.67 - $2.95 $198,252 - $350,206
118,714 Added 20.7%
692,287 $1.22 Million
Q4 2020

Feb 16, 2021
SELL
$1.8 - $2.56 $284,670 - $404,864
-158,150 Reduced 21.61%
573,573 $1.12 Million
Q3 2020

Nov 16, 2020
BUY
$2.04 - $3.74 $295,404 - $541,574
144,806 Added 24.67%
731,723 $2,000
Q2 2020

Aug 14, 2020
SELL
$2.42 - $3.29 $330,354 - $449,117
-136,510 Reduced 18.87%
586,917 $1.72 Million
Q1 2020

May 15, 2020
SELL
$1.5 - $4.59 $776,049 - $2.37 Million
-517,366 Reduced 41.7%
723,427 $2.08 Million
Q4 2019

Feb 14, 2020
SELL
$3.89 - $5.15 $1.28 Million - $1.7 Million
-329,615 Reduced 20.99%
1,240,793 $4.96 Million
Q3 2019

Nov 14, 2019
SELL
$3.19 - $5.39 $1.9 Million - $3.21 Million
-595,992 Reduced 27.51%
1,570,408 $6.99 Million
Q2 2019

Aug 14, 2019
BUY
$3.52 - $5.24 $6.83 Million - $10.2 Million
1,941,400 Added 862.84%
2,166,400 $8.38 Million
Q1 2019

May 15, 2019
BUY
$2.61 - $4.35 $587,250 - $978,749
225,000 New
225,000 $853,000

Others Institutions Holding ADMA

# of Institutions
274
Shares Held
178M
Call Options Held
535K
Put Options Held
21.2K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.08B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email